Vimpat

Vimpat Indications/Uses

lacosamide

Manufacturer:

UCB

Distributor:

Zuellig Pharma

Marketer:

Abbott
Full Prescribing Info
Indications/Uses
VIMPAT is indicated as: Monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 16 years and older.
Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in